BioSpace News Archive

Vivos Inc (OTCQB:RDGL), a company that has developed an Yttrium-90 based injectable brachytherapy device, for the treatment of tumors in animals and in humans, today announced that it will be presenting at the LD 500 investor conference on Thursday September 3 at 1:40 PST / 4:00 PM EST.

Shattuck Labs, Inc. (“Shattuck”), an innovative clinical-stage biotechnology company advancing its proprietary Agonist Redirected Checkpoint (ARC®) platform to develop an entirely new class of biologic medicines for the treatment of cancer and autoimmune disease, today announced its presentation at the PEGS Summit 2020 being held virtually August 31 – September 4, 2020.

New Orders and Production Growing; Employment Contracting; Supplier Deliveries Slowing at Faster Rate; Backlog Growing; Raw Materials Inventories Contracting; Customers’ Inventories Too Low; Prices Increasing; Exports and Imports Growing

SignalPath today announced another key addition to their executive team. Andy Corts has joined SignalPath as Senior Vice President of Sponsor and CRO Solutions.

Northwest Biotherapeutics (OTCQB: NWBO) (“NW Bio”), a biotechnology company developing DCVax ® personalized immune therapies for solid tumor cancers, today announced t

Mesara will guide communications and marketing strategy for the independent biomedical research and treatment center

Nordic Nanovector ASA (OSE: NANO) announces that its management team will present a corporate overview and host one-on-one meetings with investors at the Pareto Securities 11 th Healthcare Conference, taking place 2 nd -3 rd September 2020 . The presentation will take place at 15:00hrs CEST on Thursday, 3 rd September. Th

Oncocyte (NYSE American:OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, today announced that it will be presenting at the LD 500 investor conference on Thursday, September 3rd at 12:20PM PST / 3:20PM EST.

Stallergenes Greer, a biopharmaceutical company specialising in treatments for allergies, announces the publication of an article titled “Personalized Medicine for allergy treatment: AIT, still a unique and unmatched model” in the EAACI’s (European Academy of Allergy and Clinical Immunology) official journal Allergy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2

Spectrum Veterinary, the U.S. leader in companion-animal allergy testing and treatment, has incorporated a new blocking reagent to advance its already fully automated allergy-testing process.